ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IIN Intricon Corporation

24.24
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Intricon Corporation NASDAQ:IIN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 24.24 24.24 24.25 0 01:00:00

IntriCon Receives CE Mark for Hearing Aid Products

17/11/2014 5:45pm

Business Wire


Intricon (NASDAQ:IIN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Intricon Charts.

Approval Represents Significant Milestone for Access into the European Value Hearing Health Market

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced it has received CE (Conformité Européenne) Mark approval for its full range of hearing aid products. CE Mark approval is based on successful completion of certain technical requirements.

Historically, the company has sold hearing aid products in Europe through other manufacturers. The CE Mark allows IntriCon to directly pursue significant value hearing health opportunities throughout the region with its wide portfolio of hearing aid products.

“CE Mark approval is another meaningful milestone in our strategic plan to drive business in the value hearing health market,” said Mark S. Gorder, president and chief executive officer of IntriCon. “We are well positioned to aggressively pursue value hearing health opportunities in Europe and form meaningful partnerships to drive future growth.”

About IntriCon CorporationHeadquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better connected devices. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.

Forward-Looking StatementsStatements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and other factors are detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2013. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.

At IntriCon:Scott Longval, CFO, 651-604-9526slongval@intricon.comorAt PadillaCRT:Matt Sullivan, 612-455-1700matt.sullivan@padillacrt.com

1 Year Intricon Chart

1 Year Intricon Chart

1 Month Intricon Chart

1 Month Intricon Chart

Your Recent History

Delayed Upgrade Clock